Dynamic Medical Technologies (4138) reported revenue of NT$131.2 million for Oct 2026, +12.3% year on year and +2.2% from the previous month. Revenue for Jan–Oct 2026 was NT$1.18 billion (+3.8% year on year).
In Oct 2026, it ranked No. 62 by revenue among 160 Biotech & Medical companies.
Monthly revenue chart
Hover over (or tap) a bar to see that month’s revenue.
Monthly revenue history
| Month | Revenue | YoY | MoM |
|---|---|---|---|
| Oct 2026 | NT$131.2 million | +12.3% | +2.2% |
| Sep 2026 | NT$128.3 million | +6.2% | +14.3% |
| Aug 2026 | NT$112.3 million | -1.3% | -4.4% |
| Jul 2026 | NT$117.4 million | +13.4% | -2.3% |
| Jun 2026 | NT$120.2 million | +7.9% | +11.8% |
| May 2026 | NT$107.6 million | -2.5% | -7.8% |
| Apr 2026 | NT$116.7 million | +10.6% | -8.1% |
| Mar 2026 | NT$127 million | +6.2% | +31.5% |
| Feb 2026 | NT$96.6 million | -18.4% | -19.0% |
| Jan 2026 | NT$119.2 million | +5.2% | -1.4% |
| Dec 2025 | NT$121 million | +1.7% | -8.7% |
| Nov 2025 | NT$132.5 million | -11.0% | +13.4% |
| Oct 2025 | NT$116.8 million | -20.5% | -3.3% |
| Sep 2025 | NT$120.8 million | -2.7% | +6.2% |
| Aug 2025 | NT$113.7 million | -0.2% | +9.8% |
| Jul 2025 | NT$103.5 million | -12.5% | -7.1% |
| Jun 2025 | NT$111.4 million | -20.6% | +1.0% |
| May 2025 | NT$110.3 million | -17.6% | +4.6% |
| Apr 2025 | NT$105.5 million | -15.1% | -11.8% |
| Mar 2025 | NT$119.6 million | -14.5% | +1.1% |
| Feb 2025 | NT$118.3 million | -4.1% | +4.4% |
| Jan 2025 | NT$113.4 million | -19.0% | -4.7% |
| Dec 2024 | NT$118.9 million | -14.9% | -20.1% |
| Nov 2024 | NT$148.9 million | +3.7% | +1.4% |
| Oct 2024 | NT$146.9 million | +16.5% | +18.3% |
Jan–Oct 2026 cumulative: NT$1.18 billion (+3.8% YoY)
Other Biotech & Medical companies
Compare with peers: Dynamic Medical Technologies vs PEC / Dynamic Medical Technologies vs Lotus Pharm / Dynamic Medical Technologies vs Bora
| Company | Revenue | YoY |
|---|---|---|
| PEC | NT$2.84 billion | +102.0% |
| Lotus Pharm | NT$2.13 billion | -22.5% |
| Bora | NT$1.99 billion | +15.9% |
| Great Tree Pharmacy | NT$1.67 billion | +1.5% |
| EXCELSIOR | NT$1.02 billion | +38.6% |
| PEGAVISION | NT$793 million | +13.0% |
| Synmosa Biopharma | NT$766.6 million | +41.2% |
| Y.S.H. | NT$749.4 million | +4.4% |
See also
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16